Skip to Main Content

Paper Details

The "rights" of precision drug development for Alzheimer's disease.
Alzheimers Res Ther
121
2019
Author NameAffiliation
Howard H FeldmanUniversity of California San Diego
  • 1 - 1

Datasets

Release 1.2